Denosumab Versus Risedronate in Glucocorticoid-Induced Osteoporosis: Final Results of a Twenty-Four-Month Randomized, Double-Blind, Double-Dummy Trial.
Saved in:
| Title: | Denosumab Versus Risedronate in Glucocorticoid-Induced Osteoporosis: Final Results of a Twenty-Four-Month Randomized, Double-Blind, Double-Dummy Trial. |
|---|---|
| Authors: | Saag KG; University of Alabama at Birmingham., Pannacciulli N; Amgen Inc., Thousand Oaks, California., Geusens P; Maastricht University, Maastricht, The Netherlands., Adachi JD; McMaster University, Hamilton, Ontario, Canada., Messina OD; Cosme Argerich Hospital, Buenos Aires, Argentina., Morales-Torres J; Hospital Aranda de la Parra, León, Mexico., Emkey R; Emkey Arthritis & Osteoporosis Clinic, Wyomissing, Pennsylvania., Butler PW; Amgen Inc., Thousand Oaks, California., Yin X; Amgen Inc., Thousand Oaks, California., Lems WF; VU University Medical Center, Amsterdam, The Netherlands. |
| Source: | Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2019 Jul; Vol. 71 (7), pp. 1174-1184. Date of Electronic Publication: 2019 May 25. |
| Publication Type: | Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 101623795 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2326-5205 (Electronic) Linking ISSN: 23265191 NLM ISO Abbreviation: Arthritis Rheumatol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2326-5205 |
|---|---|
| DOI: | 10.1002/art.40874 |
